Paul R Territo Selected Research

Paul R Territo Research Topics

Disease

5	Neuroinflammatory Diseases 01/2021 - 03/2015
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2017
3	Neoplasms (Cancer) 12/2017 - 01/2014
2	Brain Injuries (Brain Injury) 01/2021 - 01/2020
2	Amyloid Plaque 01/2021 - 12/2020
2	Abscess 01/2018 - 01/2018
2	Infections 01/2018 - 01/2018
1	Placenta Accreta 01/2021
1	Postpartum Hemorrhage 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Chronic Renal Insufficiency 10/2019
1	Meckel syndrome type 3 01/2019
1	Atrophy 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hydrocephalus (Hydrocephaly) 01/2019
1	Atherosclerosis 11/2018
1	Vascular Calcification 11/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2017
1	Hemorrhage 10/2017
1	Shock 10/2017
1	Sepsis (Septicemia) 07/2017
1	Vascular Remodeling 04/2017
1	Pulmonary Embolism 04/2017
1	Pulmonary Hypertension 04/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Ganglion Cysts (Ganglion) 01/2017
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Triple Negative Breast Neoplasms 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 05/2015
1	Hypoxia (Hypoxemia) 09/2014
1	Acute Lung Injury 09/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2014
1	Hyperglycemia 07/2014
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Nervous System Diseases (Neurological Disorders) 01/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2014
2	Purinergic P2X7 ReceptorsIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018 - 05/2015
2	Leukotriene B4IBA 01/2018 - 01/2018
2	CytokinesIBA 01/2018 - 07/2017
2	ChemokinesIBA 01/2018 - 01/2018
1	SugarsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	RadiopharmaceuticalsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Amyloid beta-PeptidesIBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Uridine Triphosphate (UTP)IBA 01/2020
1	Diphosphonates (Bisphosphonates)IBA 10/2019
1	Secretin FDA Link 01/2019
1	Molecular Probes (Molecular Probe)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	CollagenIBA 01/2018
1	LipidsIBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2018
1	Sunitinib (Sutent)FDA Link 12/2017
1	TransferasesIBA 12/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017
1	Histones (Histone)IBA 12/2017
1	Phosphotransferases (Kinase)IBA 07/2017
1	Peptides (Polypeptides)IBA 07/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2017
1	Purinergic Receptors (Receptors, Purine)IBA 01/2017
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017
1	Purinergic P2X4 ReceptorsIBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	nutlin 3IBA 12/2015
1	Proto-Oncogene Proteins c-mdm2IBA 12/2015
1	EndotoxinsIBA 03/2015
1	LipopolysaccharidesIBA 03/2015
1	HMGB1 Protein (HMG1)IBA 09/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2014
1	LuciferinsIBA 01/2014
1	LuciferasesIBA 01/2014
1	enhanced green fluorescent proteinIBA 01/2014
1	methyl ester (1R- (exo,exo))- 3- (4- fluorophenyl)- 8- methyl- 8- azabicyclo(3.2.1)octane-2-carboxylic acidIBA 01/2009

Therapy/Procedure

2	Therapeutics 12/2015 - 01/2014
1	Hysterectomy 01/2021
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2017
1	Ligation 07/2017
1	Punctures 07/2017
1	Sympathectomy (Sympathectomies) 01/2017
1	Lung Transplantation 09/2014
1	Transplantation 09/2014
1	Islets of Langerhans Transplantation 07/2014